Uber Receives Mixed Analyst Ratings Amid Robotaxi Service Milestone
Uber Technologies received analyst rating updates with varied price targets, while announcing robotaxi service progress including production vehicles and autonomous testing.
Uber Technologies received analyst rating updates with varied price targets, while announcing robotaxi service progress including production vehicles and autonomous testing.
AMD introduced Ryzen AI Embedded processors on Jan 5 for edge AI applications and expanded its collaboration with HPE on Jan 2 for scalable AI infrastructure.
Eli Lilly's Taltz and Zepbound show superior efficacy in a Phase 3b trial for psoriatic arthritis and obesity. The company also agreed to acquire Ventyx Biosciences for about $1.2 billion.
Stifel and Wells Fargo adjusted ServiceNow's price targets in early January, maintaining positive ratings. The updates followed the company's announcement of its Q4 and full-year earnings release date.
Piper Sandler upgraded Arista Networks to Overweight with a $159 price target on January 5, citing 2026 as a 'Year of Refresh.' Melius Research maintained a Buy rating with a $200 target, while Morgan Stanley cut its target to $159 on December 17 but kept an Overweight rating.
Truist initiated coverage of Palantir with a Buy rating and $223 target, citing AI-driven growth, while RBC Capital reiterated a Sell rating with a $50 target.
Cantor Fitzgerald raised KLA Corporation's price target to $1,750 on January 8, maintaining an Overweight rating. The firm cited high conviction and anticipated growth in wafer fabrication equipment through 2028.
Berkshire Hathaway holds nearly 3 million Domino's Pizza shares. The pizza chain reported sales growth and expansion, with its stock trading at an attractive valuation.
AT&T received analyst rating updates in January, including a Buy from Bernstein and downgrades from KeyBanc and Arete. The company also announced a partnership with American Airlines for free in-flight Wi-Fi.
Fortinet received updated ratings from RBC Capital and Piper Sandler on January 5, with price targets adjusted. The company will announce its fiscal Q4 and full-year 2025 results on February 5.
Pfizer announced positive results from a BREAKWATER trial cohort for BRAFTOVI in metastatic colorectal cancer, showing a 64% response rate. The company also received recent analyst ratings.
Freedom Capital and Citi reduced JD.com's price targets, citing advertising costs and weak sales. JD Property announced a Saudi logistics investment.
The Alta Group has published its 2026 Insights report, identifying AI and capital expenditure shifts as key factors shaping equipment finance strategies, with new features like Alta Pulsepoint mapping market risks and opportunities.
Cenovus Energy Inc. (CVE) received several Buy ratings from financial institutions in December and January, including National Bank and Goldman Sachs, after announcing its 2026 capital budget.
Barclays raised Vale's price target to $15.50 on January 8, while Scotiabank downgraded it to Sector Perform. Wells Fargo increased its target to $13 in December, citing supply constraints.